1. Home
  2. GHRS vs SBSI Comparison

GHRS vs SBSI Comparison

Compare GHRS & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • SBSI
  • Stock Information
  • Founded
  • GHRS 2018
  • SBSI 1960
  • Country
  • GHRS Ireland
  • SBSI United States
  • Employees
  • GHRS N/A
  • SBSI N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • SBSI Major Banks
  • Sector
  • GHRS Health Care
  • SBSI Finance
  • Exchange
  • GHRS Nasdaq
  • SBSI Nasdaq
  • Market Cap
  • GHRS 849.8M
  • SBSI 874.1M
  • IPO Year
  • GHRS 2021
  • SBSI N/A
  • Fundamental
  • Price
  • GHRS $12.31
  • SBSI $27.93
  • Analyst Decision
  • GHRS Strong Buy
  • SBSI Hold
  • Analyst Count
  • GHRS 8
  • SBSI 2
  • Target Price
  • GHRS $30.63
  • SBSI $37.00
  • AVG Volume (30 Days)
  • GHRS 187.6K
  • SBSI 106.1K
  • Earning Date
  • GHRS 05-08-2025
  • SBSI 07-24-2025
  • Dividend Yield
  • GHRS N/A
  • SBSI 5.12%
  • EPS Growth
  • GHRS N/A
  • SBSI 7.94
  • EPS
  • GHRS N/A
  • SBSI 2.91
  • Revenue
  • GHRS N/A
  • SBSI $254,817,000.00
  • Revenue This Year
  • GHRS N/A
  • SBSI $10.28
  • Revenue Next Year
  • GHRS N/A
  • SBSI $5.20
  • P/E Ratio
  • GHRS N/A
  • SBSI $9.66
  • Revenue Growth
  • GHRS N/A
  • SBSI 6.49
  • 52 Week Low
  • GHRS $6.00
  • SBSI $25.78
  • 52 Week High
  • GHRS $20.50
  • SBSI $38.00
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.37
  • SBSI 44.58
  • Support Level
  • GHRS $12.43
  • SBSI $27.65
  • Resistance Level
  • GHRS $13.15
  • SBSI $28.71
  • Average True Range (ATR)
  • GHRS 0.99
  • SBSI 0.50
  • MACD
  • GHRS -0.14
  • SBSI -0.04
  • Stochastic Oscillator
  • GHRS 41.03
  • SBSI 18.30

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

Share on Social Networks: